 |
|
|
| |
Safety and Pharmacokinetics of MK-8527 Oral Once-Monthly:
A Phase 2 Study in Adults at Low Risk of HIV-1 Exposure, oral
|
| |
| |
IAS 2025 July 13-17 Rwanda
Mayer K, Kotze P, Lombaard J, Caraco Y, Peer A, Poovan N, Khalsa S, Khetan S, Shapiro AE, Rassool M, Gonzalez A, Singh Y, Sinclair G, Riddler S, Buchbinder S, Vesay M, Homony B, Evans B, Grandhi A, Zhang C, Skataric M, Robertson MN, Kapoor Y, Matthews RP, Plank RM
|
| |
|
|
|
|
|
